Correction to: High efficacy of BGD (bendamustine, gemcitabine, and dexamethasone) in relapsed/refractory Hodgkin lymphoma

A Correction to this paper has been published: https://doi.org/10.1007/s00277-021-04503-1

Saved in:
Bibliographic Details
Published inAnnals of hematology Vol. 100; no. 7; p. 1919
Main Authors Swoboda, Ryszard, Giebel, Sebastian, Knopińska-Posłuszny, Wanda, Chmielowska, Ewa, Drozd-Sokołowska, Joanna, Paszkiewicz-Kozik, Ewa, Kulikowski, Waldemar, Taszner, Michał, Mendrek, Włodzimierz, Najda, Jacek, Czerw, Tomasz, Olszewska-Szopa, Magdalena, Czyż, Anna, Giza, Agnieszka, Spychałowicz, Wojciech, Subocz, Edyta, Szwedyk, Paweł, Krzywon, Aleksandra, Wilk, Agata, Zaucha, Jan Maciej
Format Journal Article
LanguageEnglish
Published Berlin/Heidelberg Springer Berlin Heidelberg 01.07.2021
Springer Nature B.V
Subjects
Correction
Hematology
Medicine
Medicine & Public Health
Oncology
Online AccessGet full text

Cover

More Information
Summary:A Correction to this paper has been published: https://doi.org/10.1007/s00277-021-04503-1
Bibliography:correction
SourceType-Other Sources-1
content type line 63
ObjectType-Correction/Retraction-1
ISSN:0939-5555
1432-0584
DOI:10.1007/s00277-021-04503-1